Hims & Hers Health Q2 EPS $(0.03) Beats $(0.06) Estimate, Sales $207.91M Beat $204.62M Estimate
Portfolio Pulse from vinayak@benzinga.com
Hims & Hers Health (NYSE:HIMS) reported Q2 earnings per share (EPS) of $(0.03), beating the analyst consensus estimate of $(0.06) by 50%. The company also reported quarterly sales of $207.91 million, surpassing the analyst consensus estimate of $204.62 million by 1.61%. These figures represent a 70% increase in EPS and an 83.08% increase in sales compared to the same period last year.
August 07, 2023 | 8:35 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Hims & Hers Health reported better than expected Q2 earnings and sales, indicating a strong financial performance. This could potentially boost investor confidence and positively impact the company's stock price in the short term.
Hims & Hers Health's Q2 earnings and sales beat analyst estimates, indicating a strong financial performance. This is likely to be viewed positively by investors, potentially leading to an increase in demand for the company's stock and a subsequent rise in its price.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100